DIPG: Clinical Trials

2 trials for DIPG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 2
Phase 21Active not recruiting 1

Follow DIPG: new trials by email Literature Review of DIPG trials Research Report on DIPG

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas
CLR 131 - Pediatric Solid Tumor, Pediatric Lymphoma
Phase 1Active not recruitingCellectar Biosciences, Inc.302019-04-302026-10-01
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Mebendazole, Vincristine, Carboplatin - Pilomyxoid Astrocytoma, Pilocytic Astrocytoma
Phase 1 / Phase 2Active not recruitingJulie Krystal102013-10-222026-08-06

Narrower conditions

Diffuse Intrinsic Pontine Glioma (2)  ·  Glioblastoma (2)  ·  Glioma (2)  ·  Gliosarcoma (2)  ·  Astrocytoma (1)  ·  Desmoplastic Small Round Cell Tumor (1)  ·  Ependymoma (1)  ·  Hodgkin Disease (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Medulloblastoma (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neuroblastoma (1)  ·  Neuroectodermal Tumors, Primitive (1)  ·  Optic Nerve Glioma (1)

Broader conditions

Brain Diseases (2)  ·  Brain Neoplasms (2)  ·  Brain Stem Neoplasms (2)  ·  Central Nervous System Diseases (2)  ·  Central Nervous System Neoplasms (2)  ·  Infratentorial Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Nervous System Diseases (2)  ·  Nervous System Neoplasms (2)  ·  Neuroectodermal Tumors (2)

Interventions

Bevacizumab (1)  ·  CLR1404 (1)  ·  Carboplatin (1)  ·  Irinotecan (1)  ·  Mebendazole (1)  ·  Temozolomide (1)  ·  Vincristine (1)

Sponsors

Cellectar Biosciences, Inc. (1)  ·  Julie Krystal (1)

Countries

United States (2)  ·  Australia (1)  ·  Canada (1)

Top investigators

Jarrod Longcor (1)  ·  Julie Krystal, MD (1)